Behavorial and physiological effects of xanthines in nonhuman primates

Psychopharmacology

Volumn 129, Issue 1, 1997, Pages 1-14

  Howell, Leonard L ^a   Coffin, Vicki L ^b   Spealman, Roger D ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adenosine antagonist; caffeine; cardiovascular system; nonhuman primates; operant behavior; phosphodiesterase inhibition; respiration; xanthines

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; 8 PHENYLTHEOPHYLLINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; ENPROFYLLINE; ISOBUTYLMETHYLXANTHINE; PHENYLISOPROPYLADENOSINE; PHOSPHODIESTERASE INHIBITOR; RECEPTOR SUBTYPE; ROLIPRAM; THEOBROMINE; THEOPHYLLINE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE; ADENOSINE RECEPTOR;

AIRWAY RESISTANCE; BEHAVIOR; CARDIOVASCULAR SYSTEM; CHRONOTROPISM; DRUG MECHANISM; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; ENZYME INHIBITION; FOOD; HUMAN; INOTROPISM; INSTRUMENTAL CONDITIONING; LEARNING; MEMORY; NONHUMAN; PHYSIOLOGY; PRIMATE; PRIORITY JOURNAL; RECEPTOR AFFINITY; REINFORCEMENT; RESPIRATORY FUNCTION; REVIEW; ANIMAL; ANIMAL BEHAVIOR; BREATHING; CARDIOVASCULAR FUNCTION; DRUG ANTAGONISM; DRUG EFFECT; HAPLORHINI;

ANIMALS; BEHAVIOR, ANIMAL; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; HAPLORHINI; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, PURINERGIC P1; RESPIRATION; XANTHINES;

EID: 0030614450     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050155     Document Type: Review

References (145)

1. Aceto MD, Carchman RA, Harris LS, Flora RE (1978) Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys. Eur J Pharmacol 50: 203-207
2. 6-(phenylisopropyl) adenosine (PIA) in mice. Life Sci 38: 577-588
3. Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Liittschwager K, Strosberg AM, Venuti MC (1986) A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties. Mol Pharmacol 29: 554-560
4. Amer MS, Kreighbaum WE (1975) Cyclic nucleotide phosphodiesterases: Properties, activators, inhibitors, structure-activity relationships, and possible role in drug development. J Pharm Sci 64: 1-37
5. Ammon HPT, Bieck PR, Mandalaz D, Verspohl EJ (1983) Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br J Clin Pharmacol 15: 701-706
6. Angus JA, Cobbin LB. Einstein R, Maguire MH (1971) Cardiovascular actions of substituted adenosine analogues. Br J Pharmacol 41: 592-599
7. Arnaud MJ (1984) Products of metabolism of caffeine. In: Dews PB (ed) Caffeine: perspectives from recent research. Springer, Berlin, Heidelberg, New York, pp 3-38
8. Barone JJ, Roberts H (1984) Human consumption of caffeine. In: Dews PB (ed) Caffeine: perspectives from recent research. Springer, Berlin, Heidelberg New York, pp 59-73
9. Barracio RA, Aggarwal AK, Phillis JW, Boron MA, Wu, PH (1984) Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat. Neurosci Lett 48 139-144
10. Beavo JA, Reifsnyder RH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150-155
11. Belardinelli L, West A, Crampton R, Berne RM (1983) Chronotropioc and dromotropoic effects of adenosine. In: Berne RM. Rail TW, Rubio R (eds) Regulatory function of adenosine. Martinus Nijhoff, The Hague, pp 377-398
12. Benowitz NL (1990) Clinical pharmacology of caffeine. Annu Rev Med 41: 277-288
13. Berthou F, Guillois B, Riche C, Dreano Y, Jacqz-Aigrain E, Beaune PH (1992) Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22: 671-680
14. Bonati M, Latini R, Tognoni G (1985) Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat and mouse. Drug Metab Rev 15[7]: 1355-1383
15. Bonnet MH, Arand DL (1992) Caffeine use as a model of acute and chronic insomnia. Sleep 15: 526-536
16. 3H]phenylxanthine. Proc Natl Acad Sci USA 77: 5547-5551
17. Bruns RF, Lu GH, Pugsley TA (1985) Towards selective adenosine antagonists. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: receptors and modulation of cell functions. IRL Press, Oxford, pp 51-58
18. 3H]NECA in rat striatal membranes. Mol Pharmacol 29: 331-346
19. Buffalo EA, Gillam MP, Allen RR, Paule MG (1993) Acute effects of caffeine on several operant behaviors in rhesus monkeys. Pharmacol Biochem Behav 46: 733-737
20. Carey GJ, Costall B, Domeney AM, Jones DNC, Naylor RJ (1992) Behavioral effects of anxiogenic agents in the common marmoset. Pharmacol Biochem Behav 42: 143-153
21. Carney JM (1982) Effects of caffeine, theophylline and theobromine on schedule-controlled responding in rats. Br J Pharmacol 75: 451-454
22. Carroll, M E, Hagen EW, Asencio M, Brauer LH (1989) Behavioral dependence on caffeine and phencyclidine in rhesus monkeys: interactive effects. Pharmacol Biochem Behav 31: 927-932
23. Choi OH, Shamim MT, Padgett WL, Daly JW (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosophodiesterase inhibitors. Life Sci 43: 387-398
24. Coffin, VL, Spealman RD (1985) Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys. J Pharmacol Exp Ther 235: 724-728
25. Coffin VL, Spealman RD (1987) Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys. J Pharmacol Exp Ther 241: 76-83
26. Coffin VL, Spealman RD (1989) Psychomotor-stimulant effects of 3-isobutyl-1- methylxanthine: comparison with caffeine and 7(2-chloroethyl)theophylline. Eur J Pharmacol 170: 35-40
27. Collis MG, Keddie JR, Ton SR (1984) Evidence that positive inotropic effects of the alkylxanthines are not due to adenosine receptor blockade. Br J Pharmacol 81: 401-407
28. Cushny AR (1913) On the pharmacology of the respiratory center. J Pharmacol Exp Ther 4: 363-398
29. Daly JW (1977) Cyclic nucleotides in the central nervous system. Plenum Press, New York
30. Daly JW (1982) Adenosine receptors: targets for future drugs. J Med Chem 25: 197-207
31. Davi MJ, Sankaran K, Simons KJ, Simons FER, Seshia MM, Rigatto H (1978) Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 92: 91-95
32. De Gubareff T. Sleator W (1965) Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium. J Pharmacol Exp Ther 148: 202-214
33. Denaro CP, Brown CR, Wilson M, Jacob P, Benowitz NL (1990) Dose-dependency of caffeine metabolism with repeated dosing. Clin Pharmacol Ther 48: 277-285
34. Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey: a measure of psychological dependence Psychopharmacologia 16: 30-48
35. Dunwiddie TV, Worth T (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 220: 70-75
36. Einstein R, Angus JA, Cobbin LB, Maguire MH (1972) Separation of vasodilator and negative chronotropic actions in analogs of adenosine. Eur J Pharmacol 19: 246-250
37. Evans EB, Wenger GR (1992) Effects of drugs of abuse on acquisition of behavioral chains in squirrel monkeys. Psychopharmacology 107: 55-60
38. Evans DB, Schenden JA, Bristol JA (1982) Adenosine receptors mediating cardiac depression. Life Sci 31: 2425-2432
39. Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108: 51-59
40. Evoniuk G, Von Borstel W, Wurtman RJ (1987a) Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl) theophylline. J Pharmacol Exp Ther 240: 428-432
41. 2-selective adenosine antagonists: in vivo characterization of cardiovascular effects. J Pharmacol Exp Ther 242: 882-887
42. Ferré S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51: 501-512
43. Finn IB, Holtzman SG (1986) Tolerance to caffeine-induced stimulation of locomotor activity in rats. J Pharniacol Exp Ther 238: 542-546
44. Finn IB, Holtzman SG (1987) Pharmacologie specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology 93: 428-434
45. Finn IB, Holtzman SG (1988) Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats. Life Sci 42: 2475-2482
46. 2 receptor agonist, in the rhesus monkey. Br J Pharniacol 107[Suppl]: 1-315
47. 1 receptor agonist, after acute and chronic dosing in the rhesus monkey. Br J Pharmacol 112[Suppl]: 1-134
48. Fredholm BB (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol Sci 1: 129-132
49. Fredholm BB (1984) Effects of methylxanthines on skeletal muscle and on respiration. In: Spiller GA (ed) The methylxanthine beverages and foods: chemistry, consumption, and health effects. Alan R. Liss, New York, pp 365-375
50. Fredholm BB, Jacobson KA, Jonzon B, Kirk KL, Li YO, Daly JW (1987) Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo. J Cardiovasc Pharmacol 9: 396-400
51. Fuller RW, Maxwell DL, Conradson TBG, Dixon CMS, Barnes PJ (1987) Circulatory and respiratory effects of infused adenosine in conscious man. Br J Clin Pharmacol 24: 309-317
52. 2 receptor agonists but not to their synergistic interaction. Eur J Pharmacol 262: 65-75
53. Gerhardt T, McCarthy J, Bancalari E (1978) Aminophylline therapy for idiopathie apnea in premature infants: effects on lung function. Pediatrics 62: 801-804
54. Gerhardt T, McCarthy J, Bancalari E (1979) Effect of aminophylline on respiratory center activity and metabolic rate in premature infants with idiopathic apnea. Pediatrics 63: 537-542
55. Ghai G, Francis JE, Williams M, Dotson RA, Hopkins MF, Cote DT, Goodman FR, Zimmerman MB (1987) Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist. J Pharmacol Exp Ther 242: 784-790
56. Gilbert RM (1984) Caffeine consumption. In: Spiller GA (ed) The methylxanthine beverages and foods: chemistry, consumption, and health effects. Alan R. Liss, New York, pp 185-213
57. Gilbert SG, Rice DC, Reuhl KR, Stavric B (1988) Adverse pregnancy outcome in the monkey (Macaca fascicularis) after chronic caffeine exposure. J Pharmacol Exp Ther 245: 1048-1053
58. Glowa JR, Spealman RD (1984) Behavioral effects of caffeine, N6-(L-phenylisopropyl)adenosine and their combination in the squirrel monkey J Pharmacol Exp Ther 231: 665-670
59. Goldberg SR, Prada JA, Katz JL (1985) Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine. Psychopharmacology 87: 272-277
60. Graham DM (1978) Caffeine - its identity, dietary sources, intake and biological effects. Nutr Rev 36: 97-102
61. Grant DM, Tang BK, Kalow W (1983) Variability in caffeine metabolism. Clin Pharmacol Ther 33: 591-602
62. Griffiths RR, Mumford GK (1995a) Caffeine - a drug of abuse? In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1699-1713
63. Griffiths RR, Mumford GK (1995b) Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans. In: Schuster CR, Gust SW, Kuhar MJ (eds) Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach (Handbook of Experimental Pharmacology 118). Springer, Berlin, Heidelberg, New York
64. Griffiths RR, Woodson PP (1988a) Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol Biochem Behav 29: 419-427
65. Griffiths, RR, Woodson PP (1988b) Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology 94: 437-451
66. Griffiths RR, Brady JV, Bradford LD (1979) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology (vol 2). Academic Press, New York, pp 163-208
67. Griffiths RR, Bigelow GE, Liebson IA (1986) Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther 239: 416-425
68. Griffiths TL, Holgate ST (1990) The role of adenosine in respiratory physiology. In: Williams M (ed) Adenosine and adenosine receptors. Humana Press, Clinton N.J., pp 381-422
69. Guengerich FP (1988) Mammalian cytochromes P-450. CRC Press, Boca Raton. Fla.
70. Haleen SJ, Evans DB (1985) Selective effects of adenosine receptor agonists upon coronary resistance and heart rate in isolated working rabbit hearts. Life Sci 36: 127-137
71. 2 receptors in rat brain. Brain Res Bull 21: 479-482
72. Hedner T, Hedner J, Jonason J, Wessberg P (1984) Effects of theophylline on adenosine-induced respiratory depression in the preterm rabbit. Eur J Respir Dis 65: 153-156
73. Hirsh K (1984) Central nervous system pharmacology of the dietary methylxanthines. In: Spiller GA (ed) The methylxanthine beverages and foods: chemistry, consumption, and health effects. Alan R. Liss, New York, pp 235-301
74. Holtzman SG (1983) Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine. Life Sci 33: 779-787
75. Holtzman SG (1990) Caffeine as a model drug of abuse. Trends Pharmacol Sci 11: 355-356
76. Holtzman SG, Finn IB (1988) Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav 29: 411-418
77. Holtzman SG, Mante S, Minneman KP (1991) Role of adenosine receptors in caffeine tolerance. J Pharmacol Exp Ther 256: 62-68
78. Howell LL (1993a) Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys. J Pharmacol Exp Ther 266: 894-903
79. Howell LL (1993b) Effects of adenosine agonists on ventilation during hypercapnia, hypoxia and hyperoxia in rhesus monkeys. J Pharmacol Exp Ther 265: 971-978
80. Howell LL (1995) Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys. J Pharmacol Exp Ther 273: 1085-1094
81. Howell LL, Byrd LD (1993) Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey. J Pharmacol Exp Ther 267: 432-439
82. Howell LL, Landrum AM (1994) Behavioral and pharmacological modulation of respiration in rhesus monkeys. J Exp Anal Behav 62: 57-72
83. Howell LL, Landrum AM (1995) Attenuation of hypoxia-induced increases in ventilation by adenosine antagonists in rhesus monkeys. Life Sci 57: 773-783
84. Howell LL, Morse WH, Spealman RD (1990) Respiratory effects of xanthines and adenosine analogs in rhesus monkeys. J Pharmacol Exp Ther 254: 786-791
85. Howell LL, Landrum AM, Oettinger LB (1995) Tolerance to the respiratory- stimulant effects of caffeine in rhesus monkeys. In: Abstracts: College on Problems of Drug Dependence, Fifty Seventh Annual Scientific Meeting, June 10-15, p 67
86. Hudzik TJ, Wenger GR (1993) Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey. J Pharmacol Exp Ther 265: 120-127
87. Katims JJ, Annau Z, Snyder SH (1983) Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J Pharmacol Exp Ther 227: 167-173
88. Katz JL, Goldberg SR (1987) Psychomotor stimulant effects of caffeine alone and in combination with an adenosine analog in the squirrel monkey. J Pharmacol Exp Ther 242: 179-187
89. Katz JL, Prada JA, Goldberg SR (1988) Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey. Pharmacol Biochem Behav 29: 429-432
90. a) receptors. J Pharmacol Exp Ther 227: 316-321
91. Kuzenko JA, Paola J (1973) Apneic attacks in the newborn treated with aminophylline. Arch Dis Child 48: 404-406
92. Lelo A, Birkett DJ, Robson RA, Miners JO (1986) Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 22: 177-182
93. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:271-310
94. Logan L, Carney JM (1984) Antagonism of the behavioral effects of L-phenylisopropyl-adenosine (L-PIA) by caffeine and its metabolites. Pharmacol Biochem Behav 21: 375-379
95. Londos C, Cooper DMF, Wolff J (1980) Subclasses of adenosine receptors. Proc Natl Acad Sci USA 77: 2251-2254
96. Lundberg DB, Breese GR, Mueller RA (1981) Aminophylline may stimulate respiration in rats by activation of dopaminergic receptors. J Pharmacol Exp Ther 217:215-221
97. Lunell E, Svedmyr N, Andersson K-E, Persson CGA (1982) Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease. Eur J Clin Pharmacol 22: 395-402
98. Maxwell DL, Fuller RW, Nolop KB, Dixon CMS, Hughes JMB (1986) The effects of adenosine on ventilatory responses to hypoxia and hypercapnia in man. J Appl Physiol 61: 1762-1766
99. Maxwell DL, Fuller RW, Conradson T-B, Dixon CMS, Hughes JMB, Barnes PJ (1987a) Oxygen and theophylline reduce the cardiorespiratory effects of adenosine infusion in man. Clin Sci 72: 13P
100. Maxwell DL, Fuller RW, Conradson T-B, Dixon CMS, Aber V, Hughes JMB, Barnes PJ (1987b) Contrasting effects of two xanthines, theophylline and enprofylline, on the cardio-respiratory stimulation of infused adenosine in man. Acta Physiol Scand 131: 459-465
101. 2 in cats. J Appl Physiol 60: 52-59
102. McKim WA (1980) The effect of caffeine, theophylline and amphetamine on operant responding of the mouse. Psychopharmacology 68: 135-138
103. McQueen DS, Ribeiro JA (1983) On the specificity and type of receptor involved in carotid body chemoreceptor activation by adenosine in the cat. Br J Pharmacol 80: 347-354
104. McQueen DS, Ribeiro JA (1986) Pharmacological characterization of the receptor involved in chemoexcitation induced by adenosine. Br J Pharmacol 88: 615-620
105. Milhorn DE, Eldridge FL, Kiley JP, Waldrop TG (1984) Prolonged inhibition of respiration following acute hypoxia in glomectomized cats. Resp Physiol 57: 331-340
106. Moss IR, Denavit-Saubie M, Eldridge FL, Gillis RA, Herkenham M, Lahiri S (1986) Neuromodulators and transmitters in respiratory control. Fed Proc 45: 2133-2147
107. Ohnishi A, Biaggioni I, Deray G, Branch RA, Jackson EK(1986) Hemodynamic effects of adenosine in conscious hypertensive and normotensive rats. Hypertension 8: 391-398
108. Olson GD, Schlitt SC (1981) Theophylline effect upon respiration and ventilation in the dog: interaction with methadone. J Pharmacol Exp Ther 217: 278-284
109. Olsson RA, Khouri EM, Bedynek JL, McLean J (1979) Coronary vasoactivity of adenosine in the conscious dog. Circ Res 45: 468-478
110. Persson CGA (1988) The pharmacology of antiasthmatic xanthines and the role of adenosine. In: Morley J (ed) Asthma reviews (vol 1). Academic Press, New York, pp 61-94
111. Persson CGA, Erjefält L (1982) Seizure activity in animals given enprofylline and theophylline, two xanthines with partly different mechanisms of action. Arch Int Pharmacodyn 258: 267-282
112. Rall TW (1990) Drugs used in the treatment of asthma. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Oilman's The pharmacological basis of therapeutics (8th edn). Pergamon Press, New York, pp 618-637
113. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268: 16887-16890
114. Ribeiro JA, McQueen DS (1984) Effects of purines on carotid chemoreceptors. In: Pallot DJ (ed) Peripheral arterial chemoreceptors. Oxford University Press, New York, pp 383-390
115. Rice DC, Gilbert SG (1990) Automated behavioral procedures for infant monkeys. Neurotoxicol Teratol 12: 429-439
116. Richmond GH (1949) Action of caffeine and aminophylline as respiratory stimulants in man. J Appl Physiol 2: 16-23
117. Robertson D, Curatolo PW (1984) The cardiovascular effects of caffeine. In: Dews PB (ed) Caffeine: perspectives from recent research. Springer, Berlin, Heidelberg. New York, pp 77-85
118. Robertson D, Wade D, Workman R, Woosley RL, Gates JA (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67: 111-117
119. Rubio R, Berne RM, Bockman EL, Curnish RR (1975) Relationship between adenosine concentration and oxygen supply in rat brain. Am J Physiol 228: 1896-1902
120. Scale TW, Abla KA, Shamim MT, Carney JM, Daly JW (1988) 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci 43: 1671-1684
121. Serafin WE (1995) Drugs used in the treatment of asthma. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) Goodman and Oilman's The pharmacological basis of therapeutics (9th edn). McGraw-Hill, New York, pp 659-682
122. Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moylan FMB (1975) Prevention of apnea and bradycardia in low-birth-weight infants. Pediatrics 55: 589-594
123. Smellie FW, Davis CW, Daly JW, Wells JN (1979) Alkylxanthines inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci 24: 2475-2481
124. Smits P, Thien T, van't Laar A (1985) Circulatory effects of caffeine in relation to the pharmacokinetics of caffeine. Am J Cardiol 56: 958-963
125. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and the behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78: 3260-3264
126. Spealman RD (1988) Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism. Psychopharmacology 95: 19-24
127. 2 receptors. Psychopharmacology 90: 419-121
128. 2 receptors. J Pharmacol Exp Ther 246: 610-618
129. Spealman RD, Madras BK, Bergman J (1989) Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther 251: 142-149
130. Stinnette MJ, Isaac W (1975) Behavioral effects of d-amphetamine and caffeine in the squirrel monkey. Eur J Pharmacol 30: 268-271
131. Thorp RH, Cobbin LB (1959) A study of the cardiovascular actions of 2-chloroadenosine. Arch Int Pharmacodyn Ther 118: 95
132. 2 adenosine receptors. Life Sci 39: 743-750
133. VanCalker D, Muller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured cells. J Neurochem 33: 999-1005
134. Vapatalo H, Onken D, Neuvonen PJ, Westermann E (1975) Stereo-specificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA) Arzneimittelforschung 25: 407-410
135. Watt AH, Routledge PA (1985) Adenosine stimulates respiration in man. Br J Clin Pharmacol 20: 503-506
136. Watt AH, Buss DC, Routledge PA (1986) Comparison of respiratory effects of intravenous adenosine in neonatal and adult rabbits. Life Sci 39: 1617-1622
137. Watt JG, Dumke PR, Cornroe JH Jr (1943) Effects of inhalation of 100 percent and 14 percent oxygen upon respiration of unanesthetized dogs before and after chemoreceptor denervation. Am J Physiol 138: 610-617
138. Weishaar RE, Cain MH, Bristol JA (1985) New generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem 28: 537-545
139. Wessberg P, Hedner J, Hedner T, Persson B, Jonason J (1985) Adenosine mechanisms in the regulation of breathing in the rat. Eur J Pharmacol 106: 59-67
140. Williams M, Francis J, Ghai G, Brunwalder A, Psychoyos S, Stone GA, Cash WD (1987) Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. J Pharmacol Exp Ther 241: 415-420
141. Winn HR, Rubio R, Berne RM (1981) Brain adenosine concentration during hypoxia in rats. Am J Physiol 241: H235-H242
142. Wise RA (1984) Neural mechanisms in the reinforcing actions of cocaine. In: Grabowski J (ed) Cocaine: pharmacology, effects and treatment of abuse (NIDA Research Monograph Ser 50). US Government Printing Office, Washington, D.C., pp 84-1326
143. Wu PH, Phillis JW, Nye MJ (1982) Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships. Life Sci 31: 2857-2867
144. 3 adenosine receptor. Proc Natl Acad Sci USA 89: 7432-7436
145. Zwyghuizen-Doorenbos A, Roehrs TA, Lipschutz L, Timms V, Roth T (1990) Effects of caffeine on alertness. Psychopharmacology 100: 36-39